GlassScriptPhysician profile
Elizabeth Crespo
NPI 1114264355
$11,673.67
in general payments reported to CMS, 2019-2025
25 companies · $4,092 in 2025
The $4,092 reported for 2025 was more than what 98% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $594 · 2022: $1,954 · 2023: $2,329 · 2024: $2,705 · 2025: $4,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,545 · Travel and Lodging: $3,579 · Education: $2.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,544.53 |
| Travel and Lodging | $3,579.00 |
| Education | $2.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,963.79 | 2022-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $2,269.27 | 2021-2025 | Watchman Flx, Avvigo Guidance System, General - Therapies |
| Abbott Laboratories | $959.79 | 2022-2025 | Mitraclip, Jot Dx |
| Medtronic, INC. | $580.80 | 2022-2024 | Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $571.24 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $472.82 | 2021-2025 | Camzyos, Eliquis |
| Shockwave Medical, INC | $388.20 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $235.65 | 2022-2025 | |
| Scpharmaceuticals INC. | $215.82 | 2024-2025 | |
| Novo Nordisk INC | $179.82 | 2022-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.74 | 2022-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $116.98 | 2021-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $106.87 | 2021-2025 | Wainua, Farxiga |
| Atricure, INC. | $100.70 | 2023-2025 | Synergy Ablation System |
| Pfizer INC. | $93.78 | 2022-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $86.38 | 2021-2024 | Repatha |
| Merck Sharp & Dohme LLC | $31.52 | 2023-2024 | Verquvo |
| Stryker Corporation | $31.35 | 2025 | Artix Mt |
| Sanofi-Aventis U.S. LLC | $21.62 | 2023 | |
| Abiomed | $18.96 | 2024 | Impella |
| Lilly USA, LLC | $18.91 | 2025 | Zepbound |
| Idorsia Pharmaceuticals US INC | $17.92 | 2025 | Tryvio |
| Bard Peripheral Vascular, INC. | $14.87 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $14.52 | 2024 | Arcalyst |
| Elutia, INC. | $10.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Crespo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.